drugset / Trial / NCT00320320
Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the feasibility and efficacy of first-line FOLFIRI discontinuation after initial 8 cycles and reintroduction after progression.
Timeline
- Start
- 2005-04
- Primary completion
- 2007-04
- Completion
- 2007-04
Outcome
Outcome not reported
Stopped (Enrollment): “Poor accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | — | — |